Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT03450343 · COMPLETED
Trial details
- NCT number
- NCT03450343
- Sponsor
- Medical University of South Carolina
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2023-08-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.